Canaccord cuts Archer Aviation stock price target on wider losses By Investing.com

Canaccord cut Archer Aviation’s price target to $12 from $13 but kept a Buy rating after Q1 results. Archer reported an adjusted EBITDA loss of $172.5 million and free cash use of about $182 million, while revenue of $1.6 million and EPS of -$0.28 both beat expectations. The company ended the quarter with $1.78 billion in cash and guided to a $185 million midpoint Q2 EBITDA loss as spending remains elevated on VTOL development and certification.

Analysis

The market is treating this as a balance-sheet story rather than a quarter story: the key signal is that cash burn remains high but still comfortably fundable, which pushes the equity debate out into the 12-18 month window instead of forcing an immediate financing overhang. That matters because in pre-revenue mobility names, the stock usually de-risks on credible capital sufficiency first, then rerates only when execution starts compounding; the current setup supports the first leg, not the second.

The sharper second-order read is that rising R&D intensity is not just cost inflation — it is evidence that management is choosing speed over optionality discipline. In this market, that can be rewarded if flight-test cadence and certification milestones stay clean, but it also increases the probability of operational slip, which would hit the stock harder than a generic burn-rate miss because the market is already valuing a path to regulated commercial scale. Competitively, the more they pull forward hybrid and defense-adjacent work, the more they blur the line between a pure eVTOL call and a broader autonomy/air-platform software and manufacturing stack.

The consensus is likely underestimating how much of the current valuation is supported by scarcity value rather than near-term fundamentals. If the company continues to clear guidance with adequate liquidity, upside comes from multiple expansion, not earnings power; if macro risk-on fades or risk capital rotates away from long-duration story stocks, the shares can easily give back recent gains despite operational progress. The real tail risk is not this quarter’s loss — it is a future capital raise being forced by any combination of certification delay, prototype setbacks, or a step-up in manufacturing capex that outruns the current cash cushion.

For competitors and suppliers, the implication is that this spend pattern is a demand signal for aerospace tooling, battery systems, avionics, and contract manufacturing capacity over the next 2-4 quarters. If Archer executes, smaller suppliers with high exposure to early production programs can see faster revenue inflection than the prime beneficiary itself, because first builds often create bottlenecks and expediting economics before unit economics improve.

Key Decisions for Investors

• Stay long ACHR only as a 6-12 month event-driven position, not a core compounder; use strength to trim into any move toward the upper end of consensus valuation because the next rerate likely requires a certification or production milestone, not just continued burn control.
• If initiating new exposure, prefer a call spread in ACHR over common stock for the next 3-6 months to express upside from milestone delivery while capping downside if flight testing or guidance slips.
• Pair trade: long ACHR / short a broader high-duration aerospace growth basket if you want to isolate company-specific execution; the thesis is that Archer can outperform on milestone cadence even if the factor tape weakens.
• Avoid adding ahead of any known capital-markets window; if burn trends stay near current pace and the stock weakens into the next 1-2 quarters, reassess for financing risk rather than valuation support.
• For suppliers, screen small-cap avionics/battery/manufacturing names with ACHR program exposure for a 2-4 quarter momentum trade; the second-order beneficiary is likely to be the pick-and-shovel layer before it is the OEM.